Boost for New Stroke-Prevention Drug

A drug being developed by Bristol-Myers Squibb and Pfizer significantly outperformed warfarin in a major stroke-prevention study, boosting the drug’s prospects in an emerging multibillion market for new blood thinners.

Speak Your Mind

Subscribe to get this amazing EBOOK FREE

Real Estate 101 - Buying Your First Home!

By subscribing to this newsletter you agree to our Privacy Policy